Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,188 | 75,657 | 69,838 | 102,873 | 154,820 |
| Marketable Securities | 341,835 | 350,243 | 377,808 | 368,668 | 323,993 |
| Receivables | 16,781 | 15,451 | 12,713 | 12,662 | 13,450 |
| Inventories | 5,264 | 5,050 | 5,571 | 5,619 | 5,129 |
| TOTAL | $439,718 | $457,015 | $475,513 | $495,678 | $502,989 |
| Non-Current Assets | |||||
| PPE Net | 2,910 | 3,015 | 2,995 | 3,146 | 3,323 |
| Investments And Advances | 0 | 15,000 | 15,000 | 15,000 | 15,000 |
| Intangibles | 158,735 | 159,842 | 160,689 | 187,627 | 187,481 |
| Other Non-Current Assets | 12,453 | 12,702 | 13,471 | 7,709 | 7,393 |
| TOTAL | $174,098 | $190,559 | $192,155 | $213,482 | $213,197 |
| Total Assets | $613,816 | $647,574 | $667,668 | $709,160 | $716,186 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,832 | 12,519 | 7,627 | 6,954 | 9,314 |
| Accrued Expenses | 47,874 | 50,557 | 46,619 | 49,695 | 43,348 |
| Other current liabilities | 26,311 | 27,511 | 27,292 | 25,515 | 24,833 |
| TOTAL | $88,017 | $90,587 | $104,075 | $104,621 | $99,872 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 279,842 | 279,898 | 277,882 | 286,286 | 297,249 |
| TOTAL | $279,842 | $279,898 | $277,882 | $286,286 | $297,249 |
| Total Liabilities | $367,859 | $370,485 | $381,957 | $390,907 | $397,121 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,958 | 42,954 | 41,439 | 41,413 | 41,248 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -386,185 | -349,695 | -310,994 | -270,017 | -262,562 |
| Other shareholders' equity | 1,172 | 781 | 57 | -1,529 | -1,083 |
| TOTAL | $245,957 | $277,089 | $285,711 | $318,253 | $319,065 |
| Total Liabilities And Equity | $613,816 | $647,574 | $667,668 | $709,160 | $716,186 |